|
SLC30A6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.018930E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.378700E-04 |
| Normal-vs-Stage2 |
1.464420E-03 |
| Normal-vs-Stage3 |
4.34350000000361E-06 |
| Normal-vs-Stage4 |
2.75829999996091E-06 |
| Stage1-vs-Stage2 |
4.389400E-01 |
| Stage1-vs-Stage3 |
6.416200E-02 |
| Stage1-vs-Stage4 |
2.078500E-02 |
| Stage2-vs-Stage3 |
6.485600E-01 |
| Stage2-vs-Stage4 |
3.287600E-01 |
| Stage3-vs-Stage4 |
4.747400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.592980E-04 |
| Normal-vs-AfricanAmerican |
2.717900E-02 |
| Normal-vs-Asian |
5.944600E-03 |
| Caucasian-vs-AfricanAmerican |
6.474200E-01 |
| Caucasian-vs-Asian |
8.917200E-01 |
| AfricanAmerican-vs-Asian |
7.632400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.65439999999717E-05 |
| Normal-vs-Female |
3.799500E-04 |
| Male-vs-Female |
2.294800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.957000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.47879999998513E-06 |
| Normal-vs-Age(61-80Yrs) |
1.50722999999742E-05 |
| Normal-vs-Age(81-100Yrs) |
1.123780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.446400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.759800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.500000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.335800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.803400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.125400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.270500E-02 |
| Classical-VS-Follicular |
2.150400E-01 |
| Classical-VS-Other |
2.010200E-01 |
| Classical-VS-Normal |
1.538450E-03 |
| Tall-VS-Follicular |
5.036600E-01 |
| Tall-VS-Other |
5.002800E-01 |
| Tall-VS-Normal |
1.574650E-04 |
| Follicular-VS-Other |
4.280400E-01 |
| Follicular-VS-Normal |
5.032000E-04 |
| Other-VS-Normal |
6.720200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.51740000000112E-05 |
| Normal-vs-N1 |
8.09670000000429E-05 |
| N0-vs-N1 |
4.510400E-01 |
|
|
